Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury.

Loetscher PD, Rossaint J, Rossaint R, Weis J, Fries M, Fahlenkamp A, Ryang YM, Grottke O, Coburn M.

Crit Care. 2009;13(6):R206. doi: 10.1186/cc8214. Epub 2009 Dec 17.

2.

Propofol: neuroprotection in an in vitro model of traumatic brain injury.

Rossaint J, Rossaint R, Weis J, Fries M, Rex S, Coburn M.

Crit Care. 2009;13(2):R61. doi: 10.1186/cc7795. Epub 2009 Apr 27.

3.

Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site.

Harris K, Armstrong SP, Campos-Pires R, Kiru L, Franks NP, Dickinson R.

Anesthesiology. 2013 Nov;119(5):1137-48. doi: 10.1097/ALN.0b013e3182a2a265.

PMID:
23867231
4.

Methods to induce primary and secondary traumatic damage in organotypic hippocampal slice cultures.

Adamchik Y, Frantseva MV, Weisspapir M, Carlen PL, Perez Velazquez JL.

Brain Res Brain Res Protoc. 2000 Apr;5(2):153-8.

PMID:
10775835
5.

The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury.

Coburn M, Maze M, Franks NP.

Crit Care Med. 2008 Feb;36(2):588-95. doi: 10.1097/01.CCM.0B013E3181611F8A6.

PMID:
18216607
6.

Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury.

Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M, Ma D.

Neurosci Lett. 2009 Sep 4;460(3):232-6. doi: 10.1016/j.neulet.2009.05.069. Epub 2009 Jun 7.

PMID:
19500647
7.

Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury.

Roehl AB, Hein M, Loetscher PD, Rossaint J, Weis J, Rossaint R, Coburn M.

BMC Neurol. 2010 Oct 21;10:97. doi: 10.1186/1471-2377-10-97.

8.

Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review.

Stutzmann JM, Mary V, Wahl F, Grosjean-Piot O, Uzan A, Pratt J.

CNS Drug Rev. 2002 Spring;8(1):1-30. Review.

9.

Argon: systematic review on neuro- and organoprotective properties of an "inert" gas.

Höllig A, Schug A, Fahlenkamp AV, Rossaint R, Coburn M; Argon Organo-Protective Network (AON).

Int J Mol Sci. 2014 Oct 10;15(10):18175-96. doi: 10.3390/ijms151018175. Review.

10.
11.

Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult.

David HN, Haelewyn B, Degoulet M, Colomb DG Jr, Risso JJ, Abraini JH.

PLoS One. 2012;7(2):e30934. doi: 10.1371/journal.pone.0030934. Epub 2012 Feb 22.

12.

Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia.

Banks P, Franks NP, Dickinson R.

Anesthesiology. 2010 Mar;112(3):614-22. doi: 10.1097/ALN.0b013e3181cea398.

PMID:
20124979
13.
14.

Argon neuroprotection.

Sanders RD, Ma D, Maze M.

Crit Care. 2010;14(1):117. doi: 10.1186/cc8847. Epub 2010 Feb 22.

15.

The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats.

Zhuang L, Yang T, Zhao H, Fidalgo AR, Vizcaychipi MP, Sanders RD, Yu B, Takata M, Johnson MR, Ma D.

Crit Care Med. 2012 Jun;40(6):1724-30. doi: 10.1097/CCM.0b013e3182452164.

PMID:
22610177
16.

Neuroprotective effects of propofol in models of cerebral ischemia: inhibition of mitochondrial swelling as a possible mechanism.

Adembri C, Venturi L, Tani A, Chiarugi A, Gramigni E, Cozzi A, Pancani T, De Gaudio RA, Pellegrini-Giampietro DE.

Anesthesiology. 2006 Jan;104(1):80-9.

PMID:
16394694
17.

Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.

Hurtado O, Moro MA, Cárdenas A, Sánchez V, Fernández-Tomé P, Leza JC, Lorenzo P, Secades JJ, Lozano R, Dávalos A, Castillo J, Lizasoain I.

Neurobiol Dis. 2005 Mar;18(2):336-45.

PMID:
15686962
18.

D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia.

Hirt L, Badaut J, Thevenet J, Granziera C, Regli L, Maurer F, Bonny C, Bogousslavsky J.

Stroke. 2004 Jul;35(7):1738-43. Epub 2004 Jun 3.

19.

Neuroprotective effects of the AMPA antagonist PNQX in oxygen-glucose deprivation in mouse hippocampal slice cultures and global cerebral ischemia in gerbils.

Montero M, Nielsen M, Rønn LC, Møller A, Noraberg J, Zimmer J.

Brain Res. 2007 Oct 26;1177:124-35. Epub 2007 Aug 24.

PMID:
17894933
20.

Neuroprotective effects of the survival promoting peptide Y-P30.

Schneeberg J, Riek-Burchardt M, Braun H, Landgraf P, Kreutz MR, Reymann KG.

Eur J Pharmacol. 2009 Aug 15;616(1-3):81-5. doi: 10.1016/j.ejphar.2009.05.029. Epub 2009 May 31.

PMID:
19490911
Items per page

Supplemental Content

Write to the Help Desk